These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34645359)

  • 1. Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices.
    Sithole T; Salek S; Mahlangu G; Walker S
    Expert Rev Clin Pharmacol; 2022 Jan; 15(1):109-119. PubMed ID: 34645359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
    Sithole T; Mahlangu G; Salek S; Walker S
    Ther Innov Regul Sci; 2021 May; 55(3):474-489. PubMed ID: 33387356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland.
    Keyter A; Salek S; Banoo S; Walker S
    Front Pharmacol; 2019; 10():228. PubMed ID: 30923501
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing operational readiness: Regulatory landscape and compliance in zimbabwe for medical devices and in vitro diagnostic medical devices.
    Chiku C; Maruta T; Mbiba F; Manasa J
    PLoS One; 2024; 19(5):e0287495. PubMed ID: 38753597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
    [No Abstract]   [Full Text] [Related]  

  • 7. Navigating regulatory landscape: A qualitative exploration of medical devices and in vitro diagnostic medical devices oversight in Zimbabwe through key stakeholder perspectives.
    Chiku C; Maruta T; Mbiba F; Manasa J
    PLoS One; 2024; 19(5):e0287415. PubMed ID: 38753856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Analysis of Applications for Registration of Generic Medicines Processed by the Medicines Control Authority of Zimbabwe.
    Samunda BT; Sithole T; Khoza S
    Ther Innov Regul Sci; 2023 Mar; 57(2):287-294. PubMed ID: 36269550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1437970. PubMed ID: 39267958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices.
    Rahalkar H; Sheppard A; Salek S
    Front Pharmacol; 2021; 12():711361. PubMed ID: 34434109
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe.
    Murombedzi C; Chirinda L; Chareka GT; Chirenje ZM; Mgodi NM
    Front Reprod Health; 2023; 5():1279124. PubMed ID: 38034413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore.
    Haqaish WSA; Obeidat H; Patel P; Walker S
    Pharmaceut Med; 2017; 31(1):21-30. PubMed ID: 28572733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore.
    Mashaki Ceyhan E; Gürsöz H; Alkan A; Coşkun H; Koyuncu O; Walker S
    Front Pharmacol; 2018; 9():9. PubMed ID: 29422861
    [No Abstract]   [Full Text] [Related]  

  • 14. The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore.
    Hashan H; Aljuffali I; Patel P; Walker S
    Pharmaceut Med; 2016; 30():37-47. PubMed ID: 26834481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1438041. PubMed ID: 39355848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities.
    Thambavita D; Galappatthy P; Jayakody RL
    J Pharm Policy Pract; 2018; 11():14. PubMed ID: 29951208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System.
    Keyter A; Gouws J; Salek S; Walker S
    Ther Innov Regul Sci; 2018 Jul; 52(4):449-458. PubMed ID: 29848046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency.
    Keyter A; Salek S; Banoo S; Walker S
    Int J Health Policy Manag; 2022 Jun; 11(6):795-809. PubMed ID: 33300773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment.
    Sithole T; Ngum N; Owusu-Asante M; Walker S; Salek S
    Int J Health Policy Manag; 2024; 13():8070. PubMed ID: 39099506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.